Injectable in situ forming drug delivery system for cancer chemotherapy using a novel tissue adhesive: Characterization and in vitro evaluation

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 66, Issue 3, 2007, Pages 383-390

  Kakinoki, Sachiro ^a   Taguchi, Tetsushi ^a   Saito, Hirofumi ^b   Tanaka, Junzo ^a   Tateishi, Tetsuya ^a  

^a NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

^b Furuuchi Chemical Corporation   (Japan)

Author keywords

Doxorubicin; Drug delivery; Human serum albumin; Hydrogel; In situ forming; Injectable; N Hydroxysuccinimide; Tartaric acid; Tissue adhesive

Indexed keywords

CARBOXYLIC ACID; CARBOXYLIC ACID DERIVATIVE; DOXORUBICIN; ESTER; HUMAN SERUM ALBUMIN; TARTARIC ACID DERIVATIVE; TISSUE ADHESIVE;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CANCER CHEMOTHERAPY; CHEMICAL BOND; CROSS LINKING; DENSITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EVALUATION; GEL; GELATION; MACROMOLECULE; PHYSICAL CHEMISTRY;

ADHESIVENESS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; GELS; INJECTIONS; NEOPLASMS; SERUM ALBUMIN; SOLUBILITY; TISSUE ADHESIVES;

EID: 34248569453     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.11.022     Document Type: Article

References (43)

1. Lee K.Y., and Mooney D.J. Hydrogels for tissue engineering. Chem. Rev. 101 (2001) 1869-1879
2. Heller J., and Hoffman A.S. Drug delivery system. In: Ratner B.D., Hoffman A.S., Schoen F.J., and Lemons J.E. (Eds). Biomaterials Science (2004), Elsevier Academic Press, California, USA 629-648
3. Panyam J., and Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55 (2003) 329-347
4. Bannon-Peppas L., and Blanchette J.O. Nanoparticle and targeted system for cancer therapy. Adv. Drug Deliv. Rev. 56 (2004) 1649-1659
5. Barraud L., Merle P., Soma E., Lefrancois L., Guerret S., Chevallier M., Dubernet C., Couvreur P., Trépo C., and Vitvitski L. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J. Hepatol. 42 (2005) 736-743
6. Kakinoki S., Yasuda C., Kaetsu I., Uchida K., Yukutake K., Nakayama M., Fujiie S., Kuroda D., Kato M., and Ohyanagi H. Preparation of poly-lactic acid microsphere containing the angiogenesis inhibitor TNP-470 with medium-chain triglyceride and the in vitro evaluation of release profiles. Eur. J. Pharm. Biopharm. 55 (2003) 155-160
7. Freiberg S., and Zhu X.X. Polymer microsphere for controlled drug release. Int. J. Pharm. 282 (2004) 1-18
8. Nishiyama N., Bae Y., Miyata K., Fukushima S., and Kataoka K. Smart polymeric micelles for gene and drug delivery. Drug Discov. Today 2 (2005) 21-26
9. Rapoport N., Pitt W.G., Sun H., and nelson J.L. Drug delivery in polymeric micelles: from in vitro to in vivo. J. Control. Release 91 (2003) 85-95
10. Mrubỳ M., Koňák C., and Ulbrich K. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J. Control. Release 103 (2005) 137-148
11. Goyal P., Goyal K., Kumar S.G., Singh A., Katare O.P., and Mishra D.N. Liposomal drug delivery systems - clinical applications. Acta Pharm. 55 (2005) 1-25
12. Kaneda Y. Virosomes: evolution of the liposome as a targeted drug delivery system. Adv. Drug Deliv. Rev. 43 (2000) 197-205
13. Saul J.M., Annapragada A., Natarajan J.V., and Bellamkonda R.V. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J. Control. Release 92 (2003) 49-67
14. Abraham S.A., Waterhouse D.N., Mayer L.D., Cullis P.R., madden T.D., and Bally M.B. The liposomal formulation of doxorubicin. Methods Enzymol. 391 (2005) 71-97
15. He H., Cao X., and Lee L.J. Design of a novel hydrogel-based intelligent system for controlled drug release. J. Control. Release 95 (2004) 391-402
16. Hoffman A.S. Hydrogels for biomedical applications. Adv. Drug Deliv. Rev. 54 (2002) 3-12
17. Gariépy E.R., and Leroux J.C. In situ-forming hydrogels - review of temperature-sensitive systems. Eur. J. Pharm. Biopharm. 58 (2004) 409-426
18. Packhaeuser C.B., Schnieders J., Oster C.G., and Kissel T. In situ forming parenteral drug delivery systems: an overview. Eur. J. Pharm. Biopharm. 58 (2004) 445-455
19. Hatefi A., and Amsden B. Biodegradable injectable in situ forming drug delivery systems. J. Control. Release 80 (2002) 9-28
20. Ibusuki S., Fuji Y., Iwamoto Y., and Matsuda T. Tissue-engineered cartilage using an injectable and in situ gelable thermoresponsive gelatin: fabrication and in vitro performance. Tissue Eng. 9 (2003) 371-384
21. Malmsten M., and Lindman B. Self-assembly in aqueous block copolymer solutions. Macromolecules 25 (1992) 5440-5445
22. Jeong B., Bae Y.H., Lee D.S., and Kim S.W. Biodegradable block copolymers as injectable drug-delivery systems. Nature 388 (1997) 860-862
23. Kuijpers A.J., Engbers G.H., Krijgsveld J., Zaat S.A.J., Dankert J., and Feijen J. Cross-linking and characterization of gelatin matrices for biomedical applications. J. Biomat. Sci. Polym. Ed. 11 (2002) 225-243
24. Taguchi T., Saito H., Uchida Y., Sakane M., Kobayashi H., Kataoka K., and Tanaka J. Bonding of soft tissues using a novel tissue adhesive consisting of a citric acid derivative and collagen. Mater. Sci. Eng. C. - Biomimetic Supramol. Syst. 24 (2004) 775-780
25. Saito H., Taguchi T., Kobayashi H., Kataoka K., Tanaka J., Murabayashi S., and Mitamura Y. Physicochemical properties of gelatin gels prepared using citric acid derivative. Mater. Sci. Eng. C. - Biomimetic Supramol. Syst. 24 (2004) 781-785
26. Aoki H., Taguchi T., Saito H., Kobayashi H., Kataoka K., and Tanaka J. Rheological evaluation of gelatin gels prepared with a citric acid derivative as a novel cross-linker. Mater. Sci. Eng. C. - Biomimetic Supramol. Syst. 24 (2004) 787-790
27. Taguchi T., Saito H., Iwasashi M., Sakane M., Uchida Y., Kakinoki S., Kobayashi H., and Tanaka J. Development of a novel glue consisting of naturally-derived biomolecules: citric acid and human serum albumin. J. Nanosci. Nanotech. 7 (2007) 742-747
28. Saito H., Taguchi T., Aoki H., Murabayashi S., Mitamura Y., Tanaka J., and Tateishi T. pH-responsive swelling behavior of collagen gels prepared by novel crosslinkers based on naturally-derived di- or tri-carboxylic acids. Acta Biomat. 3 (2007) 89-94
29. Radosevich M., Goubran H.A., and Burnouf T. Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Vox Sang. 72 (1997) 133-143
30. Braunwald N.S., Gay W., and Tatooles C.J. Evaluation of crosslinked gelatin as a tissue adhesive and hemostatic agent: an experimental study. Surgery 59 (1966) 1024-1030
31. Yu B.G., Kwon I.C., Kim Y.H., Han D.K., Park K.D., Han K., and Jeong S.Y. Development of a local antibiotic delivery system using fibrin glue. J. Control. Release 39 (1996) 65-70
32. Kitazawa H., Sato H., Adachi I., Masuko Y., and Horikoshi I. Microdialysis assessment of fibrin glue containing sodium alginate for local delivery of doxorubicin in tumor-bearing rats. Biol. Pharm. Bull. 20 (1997) 278-281
33. Yoshida H., Yamaoka Y., Shinoyama M., and Kamiya A. Novel drug delivery system using autologous fibrin glue-release properties of anti-cancer drugs -. Biol. Pharm. Bull. 23 (2000) 371-374
34. Peters Jr. T. All About Albumin: Biochemistry, Genetics and Medical Applications (1995), Academic press, San Diego, USA
35. Blum R.H., and Carter S.K. Adriamycin. A new anticancer drug with significant clinical activity. Ann. Intern. Med. 80 (1974) 249-259
36. Aubel-Sadron G., and Londos-Gagliardi D. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review. Biochimie 66 (1984) 333-352
37. Iwata H., Matsuda S., Mitsuhashi K., Itoh E., and Ikada Y. A novel surgical glue composed of gelatin N-hydroxysuccinimide activated poly(l-glutamic acid) Part 1. Synthesis of activated poly(l-glutamic acid) its gelation with gelatin. Biomaterials 19 (1998) 1869-1876
38. Flory P.J., and Rehner Jr. J. Statistical mechanics of cross-linked polymer networks. J. Chem. Phys. 11 (1943) 512-520
39. Figuly G.D., Royce S.D., Khasat N.P., Schock L.E., Wu S.D., Davidson F., Campbell Jr. G.C., Keating M.Y., Chen H.W., Shimshick E.J., Fischer R.T., Grimminger L.C., Thomas B.E., Smith L.H., and Gillies P.J. Preparation and characterization of novel poly(alkylamine)-based hydrogels designed for use as bile acid sequestrants. Macromolecules 30 (1997) 6174-6184
40. Lee K.Y., Bouhadir K.H., and Mooney D.J. Degradation behavior of covalently cross-linked poly(aldehyde guluronate) hydrogels. Macromolecules 33 (2000) 97-101
41. Beijnen J.H., van der Houwen O.A.G.J., and Underberg W.J.M. Aspect of the degradation kinetics of doxorubicin in aqueous solution. Int. J. Pharm. 32 (1986) 123-131
42. Maniez-Devos D.M., Baurain R., Lesne M., and Trouet A. Degradation of doxorubicin and daunorubicin in human and rabbit biological fluids. J. Pharm. Biomed. Anal. 4 (1986) 353-365
43. Allen J.S., and Panfili J. Ames Salmonella/mammalian-microsome testing of peptides and peptide synthesis reagents. Mut. Res. 170 (1986) 23-29